These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Discovery of new dual binding TNKS inhibitors of Wnt signaling inhibition by pharmacophore modeling, molecular docking and bioassay. Pu Y; Zhang S; Chang Z; Zhang Y; Wang D; Zhang L; Li Y; Zuo Z Mol Biosyst; 2017 Jan; 13(2):363-370. PubMed ID: 27995250 [TBL] [Abstract][Full Text] [Related]
6. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches. Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340 [TBL] [Abstract][Full Text] [Related]
7. Time-Domain Analysis of Molecular Dynamics Trajectories Using Deep Neural Networks: Application to Activity Ranking of Tankyrase Inhibitors. Berishvili VP; Perkin VO; Voronkov AE; Radchenko EV; Syed R; Venkata Ramana Reddy C; Pillay V; Kumar P; Choonara YE; Kamal A; Palyulin VA J Chem Inf Model; 2019 Aug; 59(8):3519-3532. PubMed ID: 31276400 [TBL] [Abstract][Full Text] [Related]
8. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors. Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133 [TBL] [Abstract][Full Text] [Related]
9. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies. Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035 [TBL] [Abstract][Full Text] [Related]
10. A Multi-step Virtual Screening Protocol for the Identification of Novel Non-acidic Microsomal Prostaglandin E Shekfeh S; Çalışkan B; Fischer K; Yalçın T; Garscha U; Werz O; Banoglu E ChemMedChem; 2019 Jan; 14(2):273-281. PubMed ID: 30537167 [TBL] [Abstract][Full Text] [Related]
13. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors. Ferrari AM; Degliesposti G; Sgobba M; Rastelli G Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536 [TBL] [Abstract][Full Text] [Related]
14. Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. Buchstaller HP; Anlauf U; Dorsch D; Kuhn D; Lehmann M; Leuthner B; Musil D; Radtki D; Ritzert C; Rohdich F; Schneider R; Esdar C J Med Chem; 2019 Sep; 62(17):7897-7909. PubMed ID: 31381853 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of isoquinolin-1(2 Yao H; Wang Y; Jiangwen M; Peng Y; Wang Z Pharmazie; 2021 Apr; 76(4):132-137. PubMed ID: 33849696 [TBL] [Abstract][Full Text] [Related]
16. Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions. Kirubakaran P; Kothandan G; Cho SJ; Muthusamy K Mol Biosyst; 2014 Feb; 10(2):281-93. PubMed ID: 24291818 [TBL] [Abstract][Full Text] [Related]
17. Machine Learning Classification Models to Improve the Docking-based Screening: A Case of PI3K-Tankyrase Inhibitors. Berishvili VP; Voronkov AE; Radchenko EV; Palyulin VA Mol Inform; 2018 Nov; 37(11):e1800030. PubMed ID: 29901257 [TBL] [Abstract][Full Text] [Related]
18. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study. Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400 [TBL] [Abstract][Full Text] [Related]
19. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells. Kulak O; Chen H; Holohan B; Wu X; He H; Borek D; Otwinowski Z; Yamaguchi K; Garofalo LA; Ma Z; Wright W; Chen C; Shay JW; Zhang X; Lum L Mol Cell Biol; 2015 Jul; 35(14):2425-35. PubMed ID: 25939383 [TBL] [Abstract][Full Text] [Related]
20. Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors. Hua Z; Bregman H; Buchanan JL; Chakka N; Guzman-Perez A; Gunaydin H; Huang X; Gu Y; Berry V; Liu J; Teffera Y; Huang L; Egge B; Emkey R; Mullady EL; Schneider S; Andrews PS; Acquaviva L; Dovey J; Mishra A; Newcomb J; Saffran D; Serafino R; Strathdee CA; Turci SM; Stanton M; Wilson C; Dimauro EF J Med Chem; 2013 Dec; 56(24):10003-15. PubMed ID: 24294969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]